Topics

Cantargia Advances Development of CAN04 Through Successful Production Scale Up

06:46 EST 14 Feb 2020 | FinanzNachrichten

STOCKHOLM, Feb. 14, 2020 /PRNewswire/ -- Cantargia AB (publ) today announced it has reached an important milestone in the development of its antibody project CAN04, currently in clinical phase IIa...

Original Article: Cantargia Advances Development of CAN04 Through Successful Production Scale Up

NEXT ARTICLE

More From BioPortfolio on "Cantargia Advances Development of CAN04 Through Successful Production Scale Up"

Quick Search

Relevant Topic

Antibodies
An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...